ArticleESMO open2020

Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study.

Eva Blondeaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.